In a significant milestone for Alzheimer’s disease treatment, the U.S. Food and Drug Administration (FDA) recently approved the groundbreaking new drug, Leqembi. The medication is poised to bring new hope and treatment options to the more than 55 million people worldwide currently diagnosed with dementia or Alzheimer’s. To better understand Leqembi’s potential impacts, let’s unpack […]
Read more
Cognitive care is no exception to the racial imbalances Black, Hispanic, Asian, and Native American individuals experience in healthcare. It is a well known fact that two-thirds of the American population living with Alzheimer’s are women, irrespective of race. Yet, they have also been historically underrepresented in clinical trials and face more barriers to accessing […]
Read more
The challenge to diagnose and treat cognitive decline in our growing aging population is great. Alzheimer’s diagnosis in the US is predicted to soar (to 13.8 million in 2060, up from 6.2 million in 2021)—and so are nationwide shortages of specialists, including geriatricians and neurologists. This one-two punch puts pressure on primary care physicians (PCPs), […]
Read more
Brain health, Alzheimer’s disease, and the hormonal changes women experience around menopause all intersect. It’s an important roundtable discussion from Neurotrack’s CEO and the experts at Midi Health.
Read more
New hire to drive business expansion amid exciting advances in Alzheimer’s treatment and care (PRESS RELEASE) Neurotrack, the leader in science-backed cognitive health solutions, announced Shawn Lemerise as its first Chief Growth Officer to support the company’s expanding business. With more than 20 years of healthcare experience, Shawn brings his expertise in the health system and provider […]
Read more
Guided intervention with a health coach may be more effective for lowering risk factors; adherence is key (PRESS RELEASE) A new study by Neurotrack, the leader in science-backed cognitive health solutions, and the University of Arkansas, finds that after only four months of intervention, health education and cognitive health coaching can lower risks and improve cognition […]
Read more
In recent weeks, the family of actor Bruce Willis (Die Hard, Pulp Fiction, The Sixth Sense) announced that he would be stepping away from his acting career due to an ongoing struggle with aphasia. We spoke with Neurotrack clinical researcher and speech-language pathologist Jennifer Myers, PhD, MS, CCC-SLP, about this condition, its connection to dementia, […]
Read more
What’s Good for the Heart is Good for the Brain. Full Stop. In a stunning and unprecedented public announcement, on May 14th, 2019, the World Health Organization issued a global call to action by publishing a list of specific guidelines to reduce the risk of dementia. In fact, it’s all contained within the first paragraph […]
Read more